Venture Capital - Energy Technology and Life Sciences
Unlike our approach in traditional private equity, Yellowstone will consider making investments in the energy technology and life sciences sector that are more at the venture (start-up) level; that may not currently involve an established product; and that likely will not involve taking control positions. The following are certain current and past investments:
- Microturbine manufacturer for distributed power generation with an IPO exit. See Capstone
Eunoe, Inc. -- Developed a pioneering, device-based treatment for Alzheimer's disease (liquidated)
Grayloc Products LLC - Manufacturer of speciality clamp connectors for the oil and gas and process industries. See Grayloc.
Myelos Neurosciences Corporation -- Peptide therapy to treat nervous system disorders and related degenerative diseases, to treat pain syndromes, and a broad range oif peripheral neuropathies, including those associated with diabetes, chemotherapy, and nerve injury; merged with Savient Pharmaceuticals. (NASDAQ: SVNT)
Sadra Medical Inc. -- Developing the next generation endovascular aortic valve replacement system. Sadra's minimally invasive approach will allow aortic valve replacement without the risks of surgery. Sadra was sold to Boston Scientific (NYSE: BSX).